v3.20.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Current assets:    
Cash $ 15,499,734 $ 12,108,582
Inventory 800,000 577,690
Vendor deposits 100,000  
Prepaid expenses 160,705 141,221
Total current assets 16,560,439 12,827,493
Property and equipment, net 184,582 180,368
Right-to-use assets, net 614,896 714,342
Other assets:    
Patents, net 359,785 364,536
Trademarks 1,125 1,125
Prepaid expenses, long term 18,221 27,410
Deposits 101,839 101,839
Total assets 17,840,887 14,217,113
Current liabilities:    
Accounts payable and accrued expenses, including $115,117 and $39,674 to related parties as of March 31, 2020 and December 31, 2019, respectively 1,033,263 1,488,776
Dividends payable 127,259 128,478
Lease liability, short term 423,673 412,288
Total current liabilities 1,584,195 2,029,542
Lease liability, long term 201,321 311,131
Total debt 1,785,516 2,340,673
Preferred Stock 205,000 215,000
Commitments and contingencies (Note 11)
Equity:    
Preferred stock 0 0
Common stock, $0.001 par value, authorized 200,000,000 shares, 26,010,318 and 23,323,087 issued and outstanding as of March 31, 2020 and December 31, 2019, respectively 26,010 23,323
Additional paid in capital 131,339,541 115,910,058
Accumulated deficit (116,122,329) (104,786,769)
Total stockholders' equity attributable to BioSig Technologies, Inc 15,243,222 11,146,612
Non-controlling interest 607,149 514,828
Total equity 15,850,371 11,661,440
Total liabilities and equity $ 17,840,887 $ 14,217,113

Source